Ganga Pharmaceuticals has informed that it enclosed certificate received from Registrar and Share Transfer Agent, KFIN Technologies confirming dematerialization of Shares, mutilation & cancellation of Share Certificates received for dematerialization during the quarter ended June 30, 2021.
The above information is a part of company’s filings submitted to BSE.